PRESS RELEASE published on 11/08/2023 at 14:30, 10 months 11 days ago Jaguar Health to Hold Investor Webcast Tuesday, November 14th at 8:30 AM Eastern Regarding Q3 2023 Financials & Corporate Updates
PRESS RELEASE published on 11/07/2023 at 14:30, 10 months 12 days ago REMINDER: Jaguar Health to Host Virtual Educational Webinar on Rare Intestinal Failure Diseases with Leading Gastroenterologists and Nutrition Experts November 8th from 1:00 PM to 2:30 PM EST
PRESS RELEASE published on 11/02/2023 at 13:30, 10 months 17 days ago Jaguar Health Enters Exclusive Crofelemer Revenue Sharing License and Commercialization Agreement with Quadri Pharmaceuticals Store for Rare Intestinal Failure Diseases in Middle East Markets
PRESS RELEASE published on 11/01/2023 at 13:30, 10 months 18 days ago Issuance of New US Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
PRESS RELEASE published on 10/30/2023 at 13:30, 10 months 20 days ago Magdalena Biosciences, a Joint Venture between Jaguar Health and Filament Health, Receives Second Tranche of Funding from One Small Planet
PRESS RELEASE published on 10/26/2023 at 14:30, 10 months 24 days ago Jaguar Health to Present November 1st at Emerging Growth Conference
PRESS RELEASE published on 10/23/2023 at 14:30, 10 months 27 days ago Magdalena Biosciences Initiates Preclinical Study to Evaluate Plant Extracts to Treat Depression, Anxiety, ADHD and Other Mental Health Indications
PRESS RELEASE published on 10/19/2023 at 14:30, 11 months ago Independent Study Conducted at Boston Children's Hospital, Harvard Medical School, Shows Potential Utility of Jaguar Health's Crofelemer for Treatment of MVID, a Rare Childhood Disease
PRESS RELEASE published on 10/18/2023 at 14:30, 11 months 1 day ago Napo Pharmaceuticals to Exhibit at the October 25-28 Annual Association of Nurses in AIDS Care (ANAC) Conference for Mytesi, the Company’s FDA-Approved Prescription Drug
PRESS RELEASE published on 10/12/2023 at 14:30, 11 months 7 days ago Jaguar Health to Present October 17 at the Lytham Partners Fall 2023 Investor Conference and October 18 at the BIO Investor Forum
Published on 09/20/2024 at 02:00, 7 hours 22 minutes ago Academy of Math and Science Celebrates Hispanic Heritage Month
Published on 09/19/2024 at 23:15, 10 hours 7 minutes ago Cypher Metaverse Inc. Announces Second Closing of Financing
Published on 09/19/2024 at 23:00, 10 hours 22 minutes ago WestJet Partners with FLYHT and NOAA to Improve Weather Forecasting in North America
Published on 09/20/2024 at 09:01, 21 minutes ago Original-Research: THE NAGA GROUP AG (von NuWays AG): BUY
Published on 09/20/2024 at 07:30, 1 hour 52 minutes ago XTPL with PLN 5.6 million of commercial sales in H1 2024 and progress on industrial projects - press release
Published on 09/20/2024 at 07:00, 2 hours 22 minutes ago Mister Spex SE: Extraordinary General Meeting adopts all resolutions as proposed by the Company’s Boards
Published on 09/20/2024 at 06:26, 2 hours 56 minutes ago Original-Research: www.warimpex.com (von East Value Research GmbH ):
Published on 09/20/2024 at 08:00, 1 hour 22 minutes ago MEDESIS PHARMA : Résultats encourageants de la première phase de l’essai clinique de phase 2a pour le traitement de la maladie d’Alzheimer avec le NanoLIthium